about
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic HepatitisRabbit Hepatitis E Virus Infections in Humans, France.Hepatitis E virus infections in blood donors, France.Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.Hepatitis E in Transplantation.Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt.HEV infection in French HIV-infected patients.HEV and transfusion-recipient risk.Malignancies in hepatitis C virus-positive and -negative kidney transplant recipients: A case-controlled study.Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response.Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient.Quantification of HEV RNA by Droplet Digital PCR.New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France.Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients.Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.Detection and quantitation of HCV RNA using real-time PCR after automated sample processing.Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.Hepatitis E virus.Performance of a commercial assay for detecting and quantifying HEV RNA in faecesVectorial Release of Hepatitis E Virus in Polarized Human HepatocytesAcute hepatitis E in French patients and neurological manifestationsA fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faecesDiversity of hepatitis E virus genotype 3Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipientsHepatitis E in the south west of France in individuals who have never visited an endemic areaPegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation[Viral hepatitis E]Hepatitis E, what's the real issue?Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV DiagnosisHepatitis E virus infections in EuropeMonitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patientsPerformance characteristics of the VIDAS® ANTI-HEV IgM and IgG assaysFailure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infectionHepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective StudyPerformance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistanceDoes HEV-3 subtype play a role in the severity of acute hepatitis E?Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin
P50
Q26740390-8DF75F6B-0EF0-44B0-9E33-77CF2E1E29FCQ33908103-0BF69E35-C68B-419F-8F99-22FB74A7A905Q34426715-490E7B58-5CFC-456F-8BE9-4BF491ACB82AQ35980098-20741101-844A-4072-9F1E-2B462C5D3984Q36212007-69C4F4D2-9B36-4C3F-8DBB-85DB60675E56Q38720607-304FD722-6B50-4930-BE14-973B93628EE9Q38969085-1B9E9DDD-8731-4605-8EDD-2A6D64D15AB1Q39081278-C7380010-C339-472A-8180-513329928759Q40130228-DBF991C8-9AA1-4C8B-B3C0-8932525FF59AQ40199766-639E7C46-28EB-47A0-BD84-DC15E6796247Q40209884-140FA617-0682-47D2-85ED-E6E70689D227Q40229301-22CCFDC6-5F7B-4EB5-849B-ECEE558DD5B4Q40399326-64F0BCB7-0204-46BF-9E17-980D6A8499C0Q40750656-9B8C48ED-60E7-422F-975F-55A76D1A008BQ40766123-7ED283A8-E9A0-4457-B1AD-88D3A60865B0Q41090802-86E29B77-E3C0-4E53-B721-63BD019F1ECEQ41728290-27D126BB-7041-4E89-AC2F-890248765E1CQ41928416-8D332B85-D834-42BD-AE26-AB7B158C1A6DQ43041343-866D1C27-D145-426B-8654-9597E6617C12Q45394398-613A0C8D-DF01-4CCB-9F05-22A73E383D14Q51051857-D5FBDC98-E0A5-4D2F-8233-33ACF5C0177FQ58576844-8FE37DD5-72FE-4A28-A529-93DDDF911257Q59350379-1B233EB6-F12F-4F69-822C-32EB6AD1B7A9Q59357746-525B5058-9E41-4782-A8BC-9A2C6BE9C78BQ59357911-65C798F8-62D3-456A-A3A9-17DEE3D205A8Q59358203-D2E6A182-1A32-4487-8C34-EAC974F59F6EQ59360229-B1C1D177-F2A6-47F9-A970-D2B2CB5387EDQ80565811-65F3296A-27E9-4394-8A9C-93FBAD6D0148Q82697539-5A942E7C-2653-4F72-AD52-074CDC8A9896Q84093692-B1E01AA1-0702-49CA-93BB-1123ACDA54B5Q89798292-034B319B-3A77-4D53-B963-EE432594536AQ90004257-C75F673C-ACAF-40B7-B7FA-BC8AED120B94Q90180205-15BC4AC1-3EC1-4546-AA68-5BDE84D7D65EQ90621081-69858933-FA95-40F1-9C10-76FF8DCFB0CFQ91112919-07D140A4-E38B-4398-B725-4791C4C04A8BQ91138209-4F6F5EA3-8580-4DEA-AF38-1AF7AAEE3D7FQ91715099-DE56B069-9E31-4D67-8234-E6AC723D2351Q91759385-C456A08C-9C7D-44F0-8EB2-2BC5FF96CF89Q91976656-AA0B837C-0715-4A21-9848-CCE8469914D6Q92027793-ED4561BB-7AE6-419C-933C-D30C8BBBB80B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Florence Abravanel
@en
Florence Abravanel
@nl
type
label
Florence Abravanel
@en
Florence Abravanel
@nl
prefLabel
Florence Abravanel
@en
Florence Abravanel
@nl
P31
P496
0000-0002-1753-1065